 | • レポートコード：MRC2302D058 • 出版社/出版日：Transparency Market Research / 2022年12月5日 • レポート形態：英語、PDF、165ページ • 納品方法：Eメール（受注後24時間以内） • 産業分類：医療機器 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の市場調査レポートは、2022年に61.2百万ドルであった世界のデジタル聴診器市場規模が2031年には118.5百万ドルとなり、予測期間の間に年平均6.9％増加すると展望しています。当レポートでは、デジタル聴診器の世界市場を調査対象とし、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要洞察、用途別（心臓・肺疾患、小児集中治療室、新生児集中治療室、医学研究、その他）分析、エンドユーザー別（病院・プライマリーセンター、診療所、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競合状況などの項目をまとめました。並びに、当レポートに記載されている企業情報には、3B Scientific、3M、AMD Global Telemedicine、Cardionics、Contec Medical Systems Co. Ltd、Eko Devices Inc、EKUORE、Foshan Hedelong Electronics、GS Technology Co., Ltd.、Imediplus Inc.、Rudolf Riester GmbH、Telemedica Inc.、Thinklabs Medical LLC、American Diagnostic Corporationなどが含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・主要洞察 ・世界のデジタル聴診器市場規模：用途別 - 心臓・肺疾患における市場規模 - 小児集中治療室における市場規模 - 新生児集中治療室における市場規模 - 医学研究における市場規模 - その他用途における市場規模 ・世界のデジタル聴診器市場規模：エンドユーザー別 - 病院・プライマリーセンターにおける市場規模 - 診療所における市場規模 - 外来手術センターにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界のデジタル聴診器市場規模：地域別 - 北米のデジタル聴診器市場規模 - ヨーロッパのデジタル聴診器市場規模 - アジア太平洋のデジタル聴診器市場規模 - 中南米のデジタル聴診器市場規模 - 中東・アフリカのデジタル聴診器市場規模 ・競合状況 |
Digital Stethoscope Market – Scope of Report
TMR’s report on the global digital stethoscope market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global digital stethoscope market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global digital stethoscope market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the digital stethoscope market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global digital stethoscope market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global digital stethoscope market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global digital stethoscope market.
The report delves into the competitive landscape of the global digital stethoscope market. Key players operating in the global digital stethoscope market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global digital stethoscope market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market digital stethoscope.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Digital Stethoscope
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Digital Stethoscope Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Key Product/Brand Analysis
5.2. Technological Advancements
5.3. Key Industry Events (Mergers & Acquisitions, Partnerships, Product Launches)
5.4. COVID-19 Impact Analysis
6. Global Digital Stethoscope Analysis and Forecast, By Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Application, 2017–2031
6.3.1. Cardiac and Pulmonary Disease
6.3.2. Pediatric Intensive Care Unit
6.3.3. Neonatal Intensive Care Unit
6.3.4. Medical Research
6.3.5. Others
6.4. Market Attractiveness By Application
7. Global Digital Stethoscope Analysis and Forecast, By End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By End-user, 2017–2031
7.3.1. Hospitals & Primary Centers
7.3.2. Clinics
7.3.3. Ambulatory Surgery Centers
7.3.4. Others
7.4. Market Attractiveness By End-user
8. Global Digital Stethoscope Analysis and Forecast, By Region
8.1. Key Findings
8.2. Market Value Forecast By Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness By Country/Region
9. North America Digital Stethoscope Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast By Application, 2017–2031
9.2.1. Cardiac and Pulmonary Disease
9.2.2. Pediatric Intensive Care Unit
9.2.3. Neonatal Intensive Care Unit
9.2.4. Medical Research
9.2.5. Others
9.3. Market Value Forecast By End-user, 2017–2031
9.3.1. Hospitals & Primary Centers
9.3.2. Clinics
9.3.3. Ambulatory Surgery Centers
9.3.4. Others
9.4. Market Value Forecast By Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Application
9.5.2. By End-user
9.5.3. By Country
10. Europe Digital Stethoscope Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Application, 2017–2031
10.2.1. Cardiac and Pulmonary Disease
10.2.2. Pediatric Intensive Care Unit
10.2.3. Neonatal Intensive Care Unit
10.2.4. Medical Research
10.2.5. Others
10.3. Market Value Forecast By End-user, 2017–2031
10.3.1. Hospitals & Primary Centers
10.3.2. Clinics
10.3.3. Ambulatory Surgery Centers
10.3.4. Others
10.4. Market Value Forecast By Country, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Application
10.5.2. By End-user
10.5.3. By Country
11. Asia Pacific Digital Stethoscope Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Application, 2017–2031
11.2.1. Cardiac and Pulmonary Disease
11.2.2. Pediatric Intensive Care Unit
11.2.3. Neonatal Intensive Care Unit
11.2.4. Medical Research
11.2.5. Others
11.3. Market Value Forecast By End-user, 2017–2031
11.3.1. Hospitals & Primary Centers
11.3.2. Clinics
11.3.3. Ambulatory Surgery Centers
11.3.4. Others
11.4. Market Value Forecast By Country, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Application
11.5.2. By End-user
11.5.3. By Country
12. Latin America Digital Stethoscope Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Application, 2017–2031
12.2.1. Cardiac and Pulmonary Disease
12.2.2. Pediatric Intensive Care Unit
12.2.3. Neonatal Intensive Care Unit
12.2.4. Medical Research
12.2.5. Others
12.3. Market Value Forecast By End-user, 2017–2031
12.3.1. Hospitals & Primary Centers
12.3.2. Clinics
12.3.3. Ambulatory Surgery Centers
12.3.4. Others
12.4. Market Value Forecast By Country, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Application
12.5.2. By End-user
12.5.3. By Country
13. Middle East & Africa Digital Stethoscope Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Application, 2017–2031
13.2.1. Cardiac and Pulmonary Disease
13.2.2. Pediatric Intensive Care Unit
13.2.3. Neonatal Intensive Care Unit
13.2.4. Medical Research
13.2.5. Others
13.3. Market Value Forecast By End-user, 2017–2031
13.3.1. Hospitals & Primary Centers
13.3.2. Clinics
13.3.3. Ambulatory Surgery Centers
13.3.4. Others
13.4. Market Value Forecast By Country, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Application
13.5.2. By End-user
13.5.3. By Country
14. Competition Landscape
14.1. Market Player – Competitive Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company (2021)
14.3. Company Profiles
14.3.1. Eko Devices Inc
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. Strategic Overview
14.3.1.5. SWOT Analysis
14.3.2. 3M
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. Strategic Overview
14.3.2.5. SWOT Analysis
14.3.3. Contec Medical Systems Co. Ltd
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. Strategic Overview
14.3.3.5. SWOT Analysis
14.3.4. Rudolf Riester GmbH
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. Strategic Overview
14.3.4.5. SWOT Analysis
14.3.5. American Diagnostic Corporation
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. Strategic Overview
14.3.5.5. SWOT Analysis
14.3.6. Thinklabs Medical LLC
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. Strategic Overview
14.3.6.5. SWOT Analysis
14.3.7. EKUORE
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. Strategic Overview
14.3.7.5. SWOT Analysis
14.3.8. 3B Scientific
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. Strategic Overview
14.3.8.5. SWOT Analysis
14.3.9. Telemedica Inc.
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. Strategic Overview
14.3.9.5. SWOT Analysis
14.3.10. AMD Global Telemedicine
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. Strategic Overview
14.3.10.5. SWOT Analysis
14.3.11. Cardionics
14.3.11.1. Company Overview
14.3.11.2. Product Portfolio
14.3.11.3. Financial Overview
14.3.11.4. Strategic Overview
14.3.11.5. SWOT Analysis
14.3.12. Thinklabs Medical Llc
14.3.12.1. Company Overview
14.3.12.2. Product Portfolio
14.3.12.3. Financial Overview
14.3.12.4. Strategic Overview
14.3.12.5. SWOT Analysis